To this end, we first quantified MYC and RUVBL1 levels in a panel of pancreatic cancer cells by immunoblotting (figure 7D) and observed a strong correlation between the levels of both proteins (figure 7E) and between their levels and sensitivity to CB-6644 as estimated in cell growth assays (figure 7F). Here, MYC is linked to pancreatic neoplasm.